 |
Recombinant secretory leucocyte protease inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Congenital alpha-1 antitrypsin deficiency |
| USA Market Approval | USA |
| USA Designation Date | 1991-03-29 00:00:00 |
| Sponsor | Amgen Inc.;3200 Walnut Street;Boulder, Colorado, 80301 |
| |
Recombinant secretory leucocyte protease inhibitor |
|---|---|
| Trade Name | |
| Orphan Indication | Congenital alpha-1 antitrypsin deficiency |
| USA Market Approval | USA |
| USA Designation Date | 1991-03-29 00:00:00 |
| Sponsor | Amgen Inc.;3200 Walnut Street;Boulder, Colorado, 80301 |